Cao Ming, Gu Zhu-Qin, Li Yuan, Zhang Hui, Dan Xiao-Juan, Cen Shan-Shan, Li Da-Wei, Chan Piu
Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
Parkinson Disease Center of Beijing Institute of Brain Disorders, Beijing, 100053, China.
Neurosci Bull. 2016 Dec;32(6):572-576. doi: 10.1007/s12264-016-0070-5. Epub 2016 Oct 3.
Olfactory dysfunction has been reported in Parkinson's disease (PD) patients carrying the LRRK2 G2019S variant in Caucasians but rarely in those with the LRRK2 G2385R variant. In this study, we performed genotyping for the LRRK2 G2385R variant in PD patients recruited from the Movement Disorder Clinic of Xuanwu Hospital in Beijing and in healthy controls randomly selected from the Beijing Longitudinal Study on Aging cohort. The "five-odor olfactory detection array", an olfactory threshold test, was used to assess olfactory function. One hundred and eighty-six participants were enrolled, comprising 43 PD patients without (iPD) and 25 with (LRRK2-PD) the LRRK2 G2385R variant, and 118 healthy controls. Our results showed that the threshold of olfactory identification was significantly worse in PD patients than in controls, but not significantly different between the iPD and LRRK2-PD groups. These findings suggested that although olfactory function in LRRK2-PD patients is impaired, it is similar to that in iPD patients.
据报道,携带LRRK2 G2019S变异的帕金森病(PD)白种人患者存在嗅觉功能障碍,但携带LRRK2 G2385R变异的患者则很少出现这种情况。在本研究中,我们对从北京宣武医院运动障碍门诊招募的PD患者以及从北京老龄化队列纵向研究中随机选取的健康对照进行了LRRK2 G2385R变异的基因分型。采用嗅觉阈值测试“五气味嗅觉检测阵列”来评估嗅觉功能。共纳入186名参与者,包括43名未携带(iPD)LRRK2 G2385R变异的PD患者、25名携带(LRRK2-PD)该变异的PD患者以及118名健康对照。我们的结果显示,PD患者的嗅觉识别阈值显著低于对照组,但iPD组和LRRK2-PD组之间无显著差异。这些发现表明,虽然LRRK2-PD患者的嗅觉功能受损,但其与iPD患者的嗅觉功能相似。